|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/22 Cemtrex Inc. 10-K/A 9/30/21 16:408K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 10-K/A Amendment to Annual Report HTML 70K 2: EX-23.1 Consent of Expert or Counsel HTML 8K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 14K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 14K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 10K 6: EX-32.2 Certification -- §906 - SOA'02 HTML 10K 11: R1 Cover HTML 74K 14: XML IDEA XML File -- Filing Summary XML 14K 12: XML XBRL Instance -- form10-ka_htm XML 25K 13: EXCEL IDEA Workbook of Financial Reports XLSX 7K 8: EX-101.DEF XBRL Definitions -- cetx-20210930_def XML 75K 9: EX-101.LAB XBRL Labels -- cetx-20210930_lab XML 105K 10: EX-101.PRE XBRL Presentations -- cetx-20210930_pre XML 72K 7: EX-101.SCH XBRL Schema -- cetx-20210930 XSD 14K 15: JSON XBRL Instance as JSON Data -- MetaLinks 27± 35K 16: ZIP XBRL Zipped Folder -- 0001493152-22-005630-xbrl Zip 30K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
i ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES ACT OF 1934
For the fiscal year ended i i September 30, i 2021 /
OR
i ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES ACT OF 1934
Commission File Number i 001-37464
(Exact name of registrant as specified in its charter)
| i Delaware | i 30-0399914 | |
| (State
or other jurisdiction of incorporation or organization) |
(I.R.S.
Employer Identification No.) |
i 276 Greenpoint Ave. Suite 208, i Brooklyn, i NY i 11222
(Address of principal executive offices) (Zip code)
Registrant telephone number, including area code: i 631- i 756-9116
Securities registered pursuant to Section 12(b) of the Act:
Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ i No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ i No ☒
Indicate by check mark whether the registrant (has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). i Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer ☐ | Accelerated filer ☐ |
| i Non-accelerated filer ☒ | Smaller reporting company i ☒ |
| Emerging growth company i ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. i ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ i No ☒
As of March 31, 2021, the number of the registrant’s common stock held by non-affiliates of the registrant was i 18,141,241 and the aggregate market value $34,105,533 based on the average bid and asked price of $1.88 on March 31, 2021.
As of February 24, 2022, the registrant had shares of common stock outstanding.
C:
Explanatory Note
Cemtrex, Inc. (the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 2 on Form 10-K/A (the “Amendment”) to our Annual Report on Form 10-K for the fiscal year ended September 30, 2021 filed with the Securities and Exchange Commission (the “SEC”) on January 21, 2022, as amended by Amendment No. 1 on Form 10-K/A filed with the SEC on January 27, 2022 (the “Annual Report”) to amend and restate Item 9A of Part II, “Controls and Procedures,” with respect to our conclusions regarding the effectiveness of our disclosure controls and procedures and our internal control over financial reporting.
The Amendment was prompted by correspondence we received from the SEC in February 2022 relating to a review by the SEC of the Annual Report. This review identified that the Company did not conclude on the effectiveness of our disclosure controls and procedures as of September 30, 2021.
Consequently, we are filing this Amendment to state that, as of September 30, 2021, our evaluation of our disclosure controls and procedures identified material weaknesses and that therefore the Company’s disclosure controls and procedures during the fiscal year were not effective. Similarly, as also stated in this Amendment, these material weaknesses resulted in management’s assessment that the Company’s internal control over financial reporting was also not effective. These material weaknesses are described in the amended and restated Item 9A filed herewith.
As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the certifications required by Rule 13a-14(a) under the Exchange Act are also being filed as exhibits to this Amendment. This Amendment should be read in conjunction with the Annual Report, which continues to speak as of the date of the Annual Report. Except as specifically noted above, this Amendment does not modify or update disclosures in the Annual Report. Accordingly, this Amendment does not reflect events occurring after the filing of the Annual Report or modify or update any related or other disclosures, other than those discussed herein.
C:
PART II
ITEM 9A. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.
Based on an evaluation under the supervision and with the participation of our management, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2021 due to the material weaknesses described below.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with GAAP. Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management, including our principal executive officer and principal accounting officer, conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control—Integrated Framework (2013). Based on its evaluation, our management concluded that as of September 30, 2021, that our internal control over financial reporting were not effective and there are material weaknesses in our internal control over financial reporting. The material weaknesses relate to the Company lacking sufficient, qualified, accounting personnel. The shortage of qualified accounting personal resulted in the Company lacking entity level controls around the review of period-end reporting processes, accounting policies and public disclosures. Additionally, the Company’s current processes and systems do not provide for necessary, timely reconciliation of certain accounts and sufficient consideration regarding recoverability of certain assets. These deficiencies are common in small companies, similar to us, with limited personnel.
In order to mitigate the material weaknesses, the Board of Directors has assigned a priority to the short-term and long-term improvement of our internal control over financial reporting. Our Board of Directors will work with management to continuously review controls and procedures to identified deficiencies and implement remediation within our internal controls over financial reporting and our disclosure controls and procedures.
This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to Commission rules that permit the Company to provide only management’s report in this annual report.
This report shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred in the year ended September 30, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
C:
PART IV
| ITEM 15 | EXHIBITS AND FINANCIAL STATEMENTS |
| (a) | Financial Statements and Notes to the Consolidated Financial Statements |
| See Index to Consolidated Financial Statements on page F-1 at beginning of attached financial statements. | |
| (b) | Exhibits |
| * | Filed herewith |
| 1 | Incorporated by reference from Form 10-12G filed on May 22, 2008. |
| 2 | Incorporated by reference from Form 8-K filed on September 10, 2009. |
| 3 | Incorporated by reference from Form 8-K filed on August 22, 2016. |
| 4 | Incorporated by reference from Form 8-K filed on July 1, 2016. |
| 5 | Incorporated by reference from Form S-8 filed on May 1, 20120 |
| 6 | Incorporated by reference from Form 8-K filed on June 12, 2019. |
| 7 | Incorporated by reference from Form 8-K/A filed on November 24, 2017. |
| 8 | Incorporated by reference from Form 8-K/A filed on September 26, 2016. |
| 9 | Incorporated by reference from Form 10-Q filed on May 28, 2021. |
| 10 | Incorporated by reference from Form S-1 filed on August 29, 2016 and as amended on November 4, 2016, November 23, 2016, and December 7, 2016. |
| 11 | Incorporated by reference from Form 8-K filed on January 24, 2017. |
| 12 | Incorporated by reference from Form 8-K filed on September 8, 2017. |
| 13 | Incorporated by reference from Form 8-K filed on February 26, 2021. |
| 14 | Incorporated by reference from Form 8-K filed on March 22, 2019. |
| 15 | Intentionally left blank |
| 16 | Incorporated by reference from Form 8-K filed on April 1, 2020. |
| 17 | Incorporated by reference from Form 8-K filed on March 9, 2020. |
| 18 | Incorporated by reference from Form 8-K filed on June 4, 2020. |
| 19 | Incorporated by reference from Form 8-K filed on June 12, 2020. |
| 20 | Incorporated by reference from Form 10-K filed on January 5, 2021. |
C:
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CEMTREX, INC. | ||
| February 28, 2022 | By: | /s/ Saagar Govil . |
| Saagar Govil, | ||
| Chairman of the Board, CEO, | ||
| President & Secretary (Principal Executive Officer) | ||
| February 28, 2022 | By: | /s/ Paul J. Wyckoff . |
| Paul J. Wyckoff, | ||
| Interim CFO (Principal Financial and Accounting Officer) | ||
Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| February 28, 2022 | By: | /s/ Saagar Govil . |
| Saagar Govil, | ||
| Chairman of the Board, CEO, | ||
| President & Secretary (Principal Executive Officer) | ||
| February 28, 2022 | By: | /s/ Paul J. Wyckoff . |
| Paul J. Wyckoff, | ||
| Interim CFO (Principal Financial and Accounting Officer) | ||
| February 28, 2022 | By: | /s/ Brian Kwon |
| Brian Kwon, | ||
| Director | ||
| February 28, 2022 | By: | /s/ Manpreet Singh |
| Manpreet Singh, | ||
| Director | ||
| February 28, 2022 | By: | /s/ Metodi Filipov |
| Metodi Filipov, | ||
| Director | ||
| February 28, 2022 | By: | /s/ Chris Wagner |
| Chris Wagner, | ||
| Director |
C:
| This ‘10-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/28/22 | CORRESP | ||
| 2/24/22 | ||||
| 1/27/22 | 10-K/A, 25-NSE | |||
| 1/21/22 | 10-K | |||
| For Period end: | 9/30/21 | 10-K, 10-K/A, NT 10-K | ||
| 5/28/21 | 10-Q | |||
| 3/31/21 | 10-Q, NT 10-Q | |||
| 2/26/21 | 8-K | |||
| 1/5/21 | 10-K | |||
| 6/12/20 | 8-K | |||
| 6/4/20 | 8-K | |||
| 4/1/20 | 8-K | |||
| 3/9/20 | 8-K | |||
| 6/12/19 | 8-K | |||
| 3/22/19 | 424B2, 424B5, 8-K | |||
| 11/24/17 | 8-K/A | |||
| 9/8/17 | 8-K | |||
| 1/24/17 | 8-K | |||
| 12/7/16 | S-1/A | |||
| 11/23/16 | CORRESP, S-1/A | |||
| 11/4/16 | 8-K/A, CORRESP, S-1/A | |||
| 9/26/16 | 8-K/A | |||
| 8/29/16 | S-1 | |||
| 8/22/16 | 8-K/A, CORRESP | |||
| 7/1/16 | 8-K | |||
| 9/10/09 | 8-K | |||
| 5/22/08 | 10-12G/A | |||
| List all Filings | ||||